LAURA WINN: Open Payments
NPI 1245501964 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,277 in 97 payments from 17 companies in 2025. Trend: 2023 $1,171 · 2024 $1,478 · 2025 $2,277
Food & beverage: $2,277
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 6 | $329 |
| E.R. Squibb & Sons, L.L.C. | 12 | $290 |
| ABBVIE INC. | 19 | $277 |
| UCB, Inc. | 8 | $259 |
| Regeneron Healthcare Solutions, Inc. | 9 | $199 |
| Amgen Inc. | 11 | $190 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $149 |
| Janssen Biotech, Inc. | 6 | $142 |
| GENZYME CORPORATION | 4 | $118 |
| Novartis Pharmaceuticals Corporation | 4 | $103 |
Products named: Zoryve, DUPIXENT, Sotyktu, SKYRIZI, OTEZLA, ILUMYA, Bimzelx, TREMFYA.
Industry payments across SC — which companies pay providers there.
